Use of beta (β)-adrenergic blocking agents began in the 1960s and has risen dramatically since then. Newer agents offer more actions and fewer side effects. Uses for the drugs continue to increase as their safety and efficacy become increasingly apparent, β block, today, has widespread application in cardiovascular disease. In addition, these agents are used in the management of endocrine disorders, neurologic situations, psychiatric disorders, gastrointestinal problems, and sensory disorders. Many new β blockers arc still investigational, and some show even greater promise for therapeutic applications in the future
Skip Nav Destination
Cardiovascular Pharmacology| May 01 1992
Beta-adrenergic Blocking Agents: Their Current Status
AACN Adv Crit Care (1992) 3 (2): 447–460.
Barbara K. Clark; Beta-adrenergic Blocking Agents: Their Current Status. AACN Adv Crit Care 1 May 1992; 3 (2): 447–460. doi: https://doi.org/10.4037/15597768-1992-2016
Download citation file:
Don't already have an account? Register